chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Five days after my vaccine, 03/06/2021, I had a strong case of vertigo. I was having hot flashes while having vertigo over the slightest movements. If my husband would turn over in the bed my vertigo would kick in and it would feel as though I was being sucked downward. This continued for about 5 days. 03/08/2021 I was evaluated by my PCP and he prescribed Zofran and Antivert. On 03/15/2021 I saw a neurologists. They ordered some tests. They did an MRI. He had prescribed a 75mg dosage of nortriptyline. The next days my eyes started to get affected. If I was looking at something that was digital I could not look at it for more than 5-6 mins without getting vertigo. My husband would say that it looked as though my eyes would glaze over. The vertigo would make me feel as though I was being sucked downward even when standing. I had a follow up with my neurologist on 03/22/2021 and was diagnosed with vertiginous migraine. On 04/01/2021 I had an appointment with a physical therapist was diagnosed with Nystagmus that was both vertical and horizonal. They eye problems lasted for about a month. I still have vertigo on and off, but it is not as intense as it was immediately after the vaccine. This has also affected my work. I am a nurse and was scheduled to do COVID vaccines and I ended up having an anxiety attack which I am not prone to having. I had an ENT visit and the results of any testing was normal. I am fluent in four languages, meaning read, write and speak. I now experience times where I have a brain fog and forget words which I never had a problem with before.
Patient looked like she started to have a seizure and started to foam in the mouth for 3 to 5 seconds. Then she came to and started feeling better. Patient reported that this happened during her first vaccine. This did not happen during the second vaccine. The booster (this RX) did cause her to have a seizure. by the time paramedics came, she was feeling much better. no treatment necessary.
had them, had the vaccine; had them, had the vaccine; pruritus; nerve pain; sores; stress; irritating; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles, pruritus, post herpetic neuralgia, skin ulcer, stress and irritability. On an unknown date, the outcome of the vaccination failure, shingles, pruritus, post herpetic neuralgia, skin ulcer, stress and irritability were unknown.   It was unknown if the reporter considered the vaccination failure, shingles, pruritus, post herpetic neuralgia, skin ulcer, stress and irritability to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 9-Jul-2022 Reporter's Comments: The patient self-reported the case via interactive digital media. The patient had them 27 times at the time of reporting. Sometimes twice in a 6-8-week period. The patient stated that stress causes mine.  They itch till patient could not stand it, nerve pain gets worse but not much pain with the sores. The patient had the vaccine, but it did not affect it.  Each time it could last from 5 days - 2 weeks.  Very irritating and patient had been to doctor and 2 specialist and nothing had helped. Additional Supportive Information:  This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting. The follow-up would not possible as no contact details were available.
Systemic: Confusion-Medium, Systemic: Fainting / Unresponsive-Medium, Additional Details: PT FAINTED AFTER GETTIN THE SHOOT AND SHE TOLD DIDN'T EAT THE WHOL DAY AND SHE HAD COVID.
Patient states she received the Pfizer two dose series at the beginning of 2021, unable to provide exact dates nor place.
Continuous pain at injection site, shoulder and back.  Sometimes pain is so intense cannot move arm.
Mother called & reported approximately 2 hours after vaccines given child started vomiting & dry heaves as well as lethargic. Grandmother brought child back in and temp. (R) was 99.1. Recommended Pedialyte & let child rest. Contact MD if worsens or persists.
Per patient, "Legs felt achy and experienced a painful feeling in her butt. Symptoms began the day  of the shot and  her persisted for at least 10 days."
Patient called 10/24/17 complaining about extreme arm pain in her left arm (where she claimed she could not lift her arm at all). Patient stated it started the evening of 10/23/17. Advised the patient to ice her arm and take ibuprofen and if symptoms worsen to call her pcp.
Site: Swelling at Injection Site-Mild, Systemic: Fainting / Unresponsive-Severe
-unusually long feeling of unwellness with the second dose. -noticeable shortness of breath especially during physical activity. - HIGHLY unusual symmetrical markings on hands.  They would become more pronounced with physical exertion.  (those markings got larger with increased heart rate)
Painful arm; Headache/head feels like it's about to explode; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Painful arm) and HEADACHE (Headache/head feels like it's about to explode) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Painful arm) and HEADACHE (Headache/head feels like it's about to explode). At the time of the report, PAIN IN EXTREMITY (Painful arm) and HEADACHE (Headache/head feels like it's about to explode) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported. No treatment information was reported by reporter.   Reporter did not allow further contact
After the second dose of Moderna my first menstrual cycle irregular in March, the length of my cycle was 37 days which is abnormal for me.  The second menstrual cycle menses was missed completely, and the cycle was a total of 47 days. Which brings the date to July which again the cycle was irregular and menses started on day 38 again very late and irregular for my cycle. I then had a pregnancy and learned at 13 weeks that I was going to have a miscarriage, there was no heartbeat at the 13 week ultrasound. I then two weeks later underwent a D&C procedure which came with excessive bleeding complications requiring hospitalization as well as extended time off from work. This entire experience has caused not only physical distress but immense mental distress as well. The D&C procedure was in October. It is now February and my menstrual cycles are still irregular.
pt recvd vax 25JUL95 & 26JUL95 report that the area surrounding the tetramune inj site was swollen to twice its size;no further clinical details were available;
This case was reported by a nurse via call center representative and described the occurrence of injection site warmth in a 19-year-old female patient who received BEXSERO (batch number 159001A, expiry date 31st March 2018). On 11th August 2017, the patient received the 1st dose of BEXSERO. On 17th August 2017, 6 days after receiving BEXSERO, the patient experienced injection site warmth, erythema and induration. The patient was treated with BENADRYL. On an unknown date, the outcome of the injection site warmth, erythema and induration were unknown. The reporter considered the injection site warmth to be related to BEXSERO. It was unknown if the reporter considered the erythema and induration to be related to BEXSERO. Additional details were reported as follows: The patient received BEXSERO in right deltoid and experienced redness, mild induration and injection site warm to touch. On 17th August 2017, the patient visited physician due to an appointment to receive other vaccines and made the physician aware of the reactions associated with the BEXSERO vaccine. At the time of reporting the outcome was unknown. Healthcare professional told the patient to take BENADRYL and wait for 5 to 6 days to go to the physician/ hospital. The reporter would like a follow up.
Hospitalized 2/13/22-2/21/22 SOB,  dyspnea, wheezing, cough, PNA, hypoxia, weakness, bradycardia,
Following injection, patient had site checked after 20 minutes with no signs of reaction.  Approximately 20 minutes later when checking sibling site, patient arm red, swollen, hot to touch.  Saw doctor, given Benadryl.
swelling at injection site; warmth at injection site; swelling under arm; pain in under arm; slept all day; headache; chills; injection site pain/tenderness in her arm at the injection site; This case was reported by a consumer via call center representative and described the occurrence of injection site swelling in a 65-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Concurrent medical conditions included osteoporosis. Concomitant products included sodium ibandronate (Boniva).   On 18th May 2020, the patient received the 2nd dose of Shingrix (intramuscular). On 18th May 2020, less than a day after receiving Shingrix, the patient experienced injection site pain, headache and chills. On 19th May 2020, the patient experienced sleepiness. On an unknown date, the patient experienced injection site swelling, injection site warmth, enlargement of lymph nodes and axillary pain. On an unknown date, the outcome of the injection site swelling, injection site warmth and injection site pain were not recovered/not resolved and the outcome of the sleepiness, headache and chills were recovered/resolved and the outcome of the enlargement of lymph nodes and axillary pain were unknown.   It was unknown if the reporter considered the injection site swelling, injection site warmth, injection site pain, sleepiness, headache, chills, enlargement of lymph nodes and axillary pain to be related to Shingrix.  Additional details were reported as follows: The age at vaccination was not reported. On 18th May 2020, after receiving the Shingrix vaccine the patient experienced chills, headache and pain at the injection site. On 19th May 2020, 1 day after receiving the vaccine, the patient was slept all day, and the chills and headache started resolving around bedtime.  The patient still had tenderness in her arm at the injection site and under her arm. It was warm to the touch at the injection site and she has swelling under her arm near her breast.  The reporter consent to follow up.
Information has been received from a physician concerning a female patient over the age of 60 who on approximately 05-NOV-2007 (2 weeks ago) was vaccinated with a 0.65 ml dose of ZOSTAVAX. On approximately 05-NOV-2007 (2 weeks ago but within 48 hours of being vaccinated) the patient returned to the doctors office with a rash around the injection site. At the time of the report the patient's status was unknown. A product quality complaint was not involved. Additional information has been requested. Follow-up information has been received from a physician concerning a 60-year-old female with no known drug allergies who on 02-NOV-2007 was vaccinated with a 0.5 ml dose of ZOSTAVAX (Merck) (lot # 658084/0888U). Concomitant therapy included losartan potassium-HCTZ, SYNTHROID and "therapy unspecified" (therapy illegible). On 05-NOV-2007 the patient developed an erythema rash 16 x 7 cm on left deltoid with no vesicles or bulla with an appearance of episode like erythematous macule. The patient did not have any recent exposure to chickenpox or shingles. On an unspecified date the patient recovered. The patient was enrolled in the varicella zoster virus identification program to identify if VZV is present and if it is present to identify if it is associated with the wild-type (WT) VZV strain or with the OKA/Merck VZV strain. Additional information has been requested.
Patient had increased muscle aches along with increased CPK levels (Max 2012 IU/L). Discharge Summary received on 2/16/2005 states myositis and rhabdomyolisis.
Began with fever and chills for two days after receiving the booster beginning on 11/3/2021,  Developed a migraine on 11/9/2021 that lasted at least 4 hours, minor rash began on the evening of 11/10/2021 and then full body hives began 11/11/2021 and has so far lasted 3 days
Pain in both pelvic limbs, left predominance, admitted to hospital for observation, admission April 23, discharged April 25, next appointment to angiologist May 3
pt was pregnant had a miscarriage was 5 days post conception when vax given & Larium started had live fetus that died @ 6 wk p/LMP
Patient says her arm is too much in pain to even move. She says its difficult to even raise her arm.  She describes it being in "bad pain" and it is much more than just a "sore arm".
Next day severe back pain, muscle spasms that lasted 4 days.  Symptoms persisted for next 8 weeks. Still not back to baseline.
Swollen spot on arm (dime size); Warm spot on arm (dime size); she noticed a spot on her left arm yesterday which was the size of the dime; This case was reported by a consumer via call center representative and described the occurrence of swelling in a 55-year-old female patient who received Herpes zoster (Shingrix) (batch number lg2xj, expiry date 10th September 2023) for prophylaxis.   On 14th December 2022, the patient received the 1st dose of Shingrix. On 19th December 2022, 5 days after receiving Shingrix, the patient experienced swelling, skin warm and papule. On an unknown date, the outcome of the swelling, skin warm and papule were not recovered/not resolved.   It was unknown if the reporter considered the swelling, skin warm and papule to be related to Shingrix.     Additional Information: GSK Receipt Date: 20-DEC-2022 Reporter's Comment: The reporter was the patient, who received her Shingrix last Wednesday. The reporter stated that she noticed a spot on her left arm yesterday which was the size of the dime which was warm and swollen.  The spot was increased today and it was still warm and swollen.  The reporter stated that it was not raised, but the swelling was under the skin. The reporter consented to follow up.
This spontaneous report was received from a pharmacist, and refers to a female patient of unknown age. Her medical history, concurrent conditions, drug reactions/allergies, and concomitant medications were not reported. On 11-MAY-2017, the patient was vaccinated with ZOSTAVAX (strength and dose were not reported) lot # M039452 with expiration date of 19-DEC-2017, intramuscularly (incorrect route of drug administration) for prophylaxis. It was reported that, since an unspecified date in 2017, the patient experienced bruising and soreness at the injection site; therefore, the patient complained of the events with the pharmacist on 15-JUN-2017 but no treatment or intervention to prevent serious criteria was performed. At the time of reporting, the outcome of injection site bruising and injection site pain was resolving. The reporter's causality assessment between injection site bruising and injection site pain with ZOSTAVAX was not provided. This is one of two cases received from the same reporter. Sender's Comments: US-009507513-1707USA000975.
ED visit for depression with suicidal ideation.  Hospital admission for bipolar disorder. Behavioral health admission and treatment. Hospital admission within 6 weeks of receiving the COVID vaccine.
This spontaneous report as received from a nurse refers to a 22 months 16 days old female patient. No concurrent condition, medical history or allergy/drug reactions were reported. On an unspecified date, the patient was vaccinated with improperly stored (exposed to 52.8 Fahrenheit for a total of 105 hours) PEDVAXHIB injection, lot # K016965, exp. date: 20-JUL-2017 (dose, strength and route unspecified). No concomitant medications were reported. No adverse experiences have been reported so far. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of several reports received from the same reporter. Additional information is not expected, no contact details were provided.
NEST DAY AFTER INJECTION, 2 SMALL RED/ RUFF DRY PATCH SHOWED UP ON HIS STOMACH, COUPLE DAYS LATER ONE SHOWED UP ON R HAND. TODAY CAN STILL SEE WHERE AREA WAS ON STOMACH AND THE ONE ON HIS R HAND IS STILL THERE.
experiencing a toothache; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer reported for a patient (daughter) that a female patient of an unspecified age received bnt162b2 (Pfizer-BioNTech COVID-19 Vaccine, solution for injection), dose 1 via an unspecified route of administration on 18Feb2021 (Batch/Lot number was not reported) as DOSE 1, SINGLE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. It was reported that reporters daughter had a scheduled 1st dose this Thursday 18Feb2021, and was experiencing a toothache on an unspecified date. Reporter was asking if Augmentin (antibiotic) from her doctor can affect the vaccine. Outcome of the event was unknown.   Follow-up attempts completed. No further information expected.
While driving home, developed itching in ears, then itchy scalp, then felt hot all over. When she arrived home (45 min drive time) she notices skin was red with macular-papular rash all over.
This spontaneous report was received from a licensed practitioner nurse and referred to a patient of unknown age and sex. No pertinent medical history, drug reactions or allergies were reported. On 14-MAR-2014, the patient was vaccinated with RECOMBIVAX HB (lot # 670230/1047AA, expiration date: 15-DEC-2013) third dose. Dates of first and second doses of RECOMBIVAX HB were unspecified. No adverse event reported. Additional information is not expected.
ADMITTED TO THE HOSPITAL 19 HOURS AFTER VACCINE FOR SEVERE DIZZINESS, NAUSEA, VOMITING, LEG WEAKNESS - UNABLE TO WALK. WILL PROVIDE NOTES UPON REQUEST,
Anthrax Lot# FAV110 administered after expired date due to administrative oversight. No adverse reaction at this time. Report submitted per Milvax direction.
Myalgia; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Myalgia) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001B21A) for COVID-19 vaccination.     No Medical History information was reported.    In April 2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In April 2021, the patient experienced MYALGIA (Myalgia). At the time of the report, MYALGIA (Myalgia) outcome was unknown. Not Provided          No concomitant medications were reported. No treatment information was provided by the reporter.   This case was linked to US-MODERNATX, INC.-MOD-2021-069810 (Linked Report).   Reporter did not allow further contact; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-069810:
fever, diarrhea , body ache , redness and swelling on vaccine site , fatigue
My arm feels like it has restless arm syndrome it feels like I am extending it when it is at rest.
Patient noticed big red area where injection was give (round area with a circumference of 2-3"; A little sore happened 2 days after injection.  Patient does not have fever.  Will use cold compresses and Benadryl and was told to use APAP if was painful.  Patient was instructed to seek medical treatment if area worsensed or fever developed.
Beginning with low fever, pain at the injection site (lasted 3 days), then by the afternoon of the vaccine, severe anxiety leading to an emergency room visit because of trouble breathing.  Complete lack of appetite, underweight patient.
Dizziness; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Diabetic and Blood pressure.    On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced DIZZINESS (Dizziness). At the time of the report, DIZZINESS (Dizziness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
This spontaneous report as received from a medical assistant refers to a patient of unknown age. The patient received doses of GARDASIL outside of recommended schedule. The patient was vaccinated with dose 1 GARDASIL (route, dose, frequency, lot# and expiration date were reported) in December 2009 and the second dose was given in July 2011. No other co-suspects were reported. No concomitant medications were reported. No adverse effects reported. Additional information has been requested.
Has a cracked tooth and getting it pulled today; This spontaneous case was reported by a consumer and describes the occurrence of TOOTH INJURY (Has a cracked tooth and getting it pulled today) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced TOOTH INJURY (Has a cracked tooth and getting it pulled today). At the time of the report, TOOTH INJURY (Has a cracked tooth and getting it pulled today) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. No treatment information was reported.
Patient was 15 weeks and 6 days at the time of administration, and the vaccine is not indicated for the first dose past 15 weeks of age.
Approximately 2 hours after receiving the dose I started to get what I believe is tinnitus but it was actually a swooshing sound in my left ear.  Within 2 weeks, I was totally deaf in my left ear.  I am currently being treated by an ENT and Neurosurgeon in and now I am going to see a Neurologist and probably a Neurosurgeon at Clinic.  I know I am not the only one.  My husband was talking to a patient  on 11/24/21 about the vaccine and she told my husband her friend and her friend's husband are having the same issue, except her friend's husband is deaf in both ears.  When they spoke to someone, not sure if it was their doctor, Pfizer or someone else, they were told not to say anything because it's a well known side effect and they don't want people to know about it because they don't want people dissuaded from getting the vaccine.  I was told my hearing may not come back.  Needless to say, I am very angry about it as I am a lawyer, I work in Medicine, and I also fly planes.  This will ground me from ever flying a plane again and it interferes substantially with my daily living activities and work.